771-28-8,MFCD06366748
Catalog No.:AA008NWL

771-28-8 | 2-Methoxybenzamidoxime

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$145.00   $102.00
- +
5g
98%
in stock  
$535.00   $375.00
- +
10g
98%
in stock  
$843.00 $590.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008NWL
Chemical Name:
2-Methoxybenzamidoxime
CAS Number:
771-28-8
Molecular Formula:
C8H10N2O2
Molecular Weight:
166.1772
MDL Number:
MFCD06366748
SMILES:
O/N=C(/c1ccccc1OC)\N
Properties
Computed Properties
 
Complexity:
170  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
1  
Formal Charge:
0  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.1  

Downstream Synthesis Route

[1]Patent:WO2009/43890,2009,A1.Locationinpatent:Page/Pagecolumn53

[2]EuropeanJournalofMedicinalChemistry,2019,vol.164,p.92-105

[3]BioorganicChemistry,2020,vol.100

[4]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.5936-5940

[5]JournalofHeterocyclicChemistry,1980,vol.17,p.819-821

[6]BioorganicandMedicinalChemistry,2000,vol.8,p.601-615

[7]JournalofMedicinalChemistry,2012,vol.55,p.68-83

[8]OrganicProcessResearchandDevelopment,2012,vol.16,p.1717-1726

[9]ChemMedChem,2019,vol.14,p.1257-1270

[1]Patent:WO2005/19184,2005,A1.Locationinpatent:Page/Pagecolumn29

[2]Patent:WO2014/141065,2014,A1.Locationinpatent:Page/Pagecolumn46;47

[3]OrganicandBiomolecularChemistry,2014,vol.12,p.8036-8047

[4]Patent:WO2018/81167,2018,A1.Locationinpatent:Page/Pagecolumn107;108

[5]JournalofMedicinalChemistry,2022,vol.65,p.5449-5461

35444-44-1    771-28-8   
5-3-(2-methoxyphenyl)-1,2,4oxadiazol-5-ylpentanoicacidmethylester 

[1]CurrentPatentAssignee:NOVONORDISKA/S-WO2005/19184,2005,A1Locationinpatent:Page/Pagecolumn29

50890-83-0    771-28-8   
2-methoxy-N'-(N-methyl-1H-indazole-3-carbonyloxy)benzimidamide 

[1]TetrahedronLetters,2016,vol.57,p.2898-2900

50890-83-0    771-28-8   
3-(2-methoxyphenyl)-5-(N-methyl-1H-indazol-3-yl)-1,2,4-oxadiazole 

[1]TetrahedronLetters,2016,vol.57,p.2898-2900

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:771-28-8 Molecular Formula|771-28-8 MDL|771-28-8 SMILES|771-28-8 2-Methoxybenzamidoxime
Catalog No.: AA008NWL
771-28-8,MFCD06366748
771-28-8 | 2-Methoxybenzamidoxime
Pack Size: 1g
Purity: 98%
in stock
$145.00 $102.00
Pack Size: 5g
Purity: 98%
in stock
$535.00 $375.00
Pack Size: 10g
Purity: 98%
in stock
$843.00 $590.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008NWL
Chemical Name: 2-Methoxybenzamidoxime
CAS Number: 771-28-8
Molecular Formula: C8H10N2O2
Molecular Weight: 166.1772
MDL Number: MFCD06366748
SMILES: O/N=C(/c1ccccc1OC)\N
Properties
Complexity: 170  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 1  
Formal Charge: 0  
Heavy Atom Count: 12  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.1  
Downstream Synthesis Route
6609-56-9    771-28-8 

[1]Patent:WO2009/43890,2009,A1.Locationinpatent:Page/Pagecolumn53

[2]EuropeanJournalofMedicinalChemistry,2019,vol.164,p.92-105

[3]BioorganicChemistry,2020,vol.100

[4]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.5936-5940

[5]JournalofHeterocyclicChemistry,1980,vol.17,p.819-821

[6]BioorganicandMedicinalChemistry,2000,vol.8,p.601-615

[7]JournalofMedicinalChemistry,2012,vol.55,p.68-83

[8]OrganicProcessResearchandDevelopment,2012,vol.16,p.1717-1726

[9]ChemMedChem,2019,vol.14,p.1257-1270

6609-56-9    771-28-8 

[1]Patent:WO2005/19184,2005,A1.Locationinpatent:Page/Pagecolumn29

[2]Patent:WO2014/141065,2014,A1.Locationinpatent:Page/Pagecolumn46;47

[3]OrganicandBiomolecularChemistry,2014,vol.12,p.8036-8047

[4]Patent:WO2018/81167,2018,A1.Locationinpatent:Page/Pagecolumn107;108

[5]JournalofMedicinalChemistry,2022,vol.65,p.5449-5461

35444-44-1    771-28-8   
5-3-(2-methoxyphenyl)-1,2,4oxadiazol-5-ylpentanoicacidmethylester 

[1]CurrentPatentAssignee:NOVONORDISKA/S-WO2005/19184,2005,A1Locationinpatent:Page/Pagecolumn29

50890-83-0    771-28-8   
2-methoxy-N'-(N-methyl-1H-indazole-3-carbonyloxy)benzimidamide 

[1]TetrahedronLetters,2016,vol.57,p.2898-2900

50890-83-0    771-28-8   
3-(2-methoxyphenyl)-5-(N-methyl-1H-indazol-3-yl)-1,2,4-oxadiazole 

[1]TetrahedronLetters,2016,vol.57,p.2898-2900

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Building Blocks More >
76006-04-7
76006-04-7
1-Acetyl-5-chloro-pyrazolo-[3,4-c]pyridine
AA008OP7 | MFCD08061149
7403-68-1
7403-68-1
2-(neopentylamino)ethanol
AA008P8T | MFCD14619786
74495-70-8
74495-70-8
4-Hydroxy-3-(methoxy-d3)-mandelic Acid
AA008PV2 | MFCD06658570
73568-33-9
73568-33-9
2,7-Dichloroquinoline-3-carboxaldehyde
AA008QKI | MFCD06202348
118492-87-8
118492-87-8
(2R,3S)-1-[(tert-butoxy)carbonyl]-3-hydroxypyrrolidine-2-carboxylic acid
AA008R1X | MFCD02682324
1117-37-9
1117-37-9
Ethyl trans-3-(N,N-dimethylamino)acrylate
AA008RAM | MFCD00144269
1073-13-8
1073-13-8
4,4-Dimethylcyclohex-2-enone
AA008RLW | MFCD00009695
1081110-72-6
1081110-72-6
H-PHE-ASN-ALA-PRO-PHE-ASP-VAL-GLY-ILE-LYS-LEU-SER-GLY-VAL-GLN-TYR-GLN-GLN-HIS-SER-GLN-ALA-LEU-NH2
AA008RTX | MFCD08458633
1020719-08-7
1020719-08-7
(R,S)-ANABASINE-2,4,5,6-D4
AA008S17 | MFCD04039400
1047652-16-3
1047652-16-3
5-Amino-6-(dimethylamino)-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one
AA008S9R | MFCD07403453
Submit
© 2017 AA BLOCKS, INC. All rights reserved.